Antibody study into autophagy reveals new part for HMGB proteins

tags

The HMGB, or higher mobility group box proteins in our antibody catalog are utilized in a assortment of research regions, predominantly histone, chromatin and transcription study. Now, an antibody study has revealed a possible new role for at least one of the HMGB proteins: as a trigger for autophagy, or spontaneous cell death.

HMGB proteins are an critical chromosomal repair group, known to also be involved in the transcription, replication and recombination of DNA. They are of interest to antibody suppliers as mutations have been implicated in the formation of benign tumours HMGB antibodies are also expressed in individuals suffering from autoimmune disease.

It seems that at least a single HMGB protein – HMGB1 – plays far more than just a passive regulatory and repair function within the cell. It generally resides in the nucleus, altering the DNA to let transcription elements to interact with other essential regulatory proteins. Nevertheless, in 2007, Sitia et al demonstrated the protein can act as an extracellular chemokine. Hepatic cells damaged by cytotoxic T lymphocytes (CTLs) released HMGB1 into the extracellular fluid, exactly where it recruited inflammatory mononucleocytes and neutrophils to the broken cells, triggering inflammation and hastening their demise.

In the latest study, Tang et al set out to establish whether HMGB1 also has a function to play in the cytosol (intracellular fluid). It was found that despite the fact that HMGB1 does not generally reside in the ICF, cells stressed by starvation released it there from the nucleus, therefore triggering commencement of autophagy. Antibody assays showed that, in response to starvation, the nucleus increased its expression of reactive oxygen species, triggering oxidation of 3 crucial cysteine domains in HMGB1. This resulted in translocation of the protein to the cytosol, exactly where it bound to Beclin-1, causing it to dissociate from Bcl-2. Usually, the Beclin-1/Bcl-two complex inhibits autophagy.

The antibody catalogue we at Novus Biologicals create is widely utilised in cancer analysis. It seems HMB1 may have a role to play there too, as tumour cells usually trigger autophagy in order to resist the effects of chemotherapy, immunotherapy and other varieties of therapy.